Approaching zero: temporal effects of a restrictive antibiotic policy on hospital-acquired Clostridium difficile, extended-spectrum β-lactamase-producing coliforms and meticillin-resistant Staphylococcus aureus
Introduction
There are continuing concerns over hospital-acquired infections (HAIs) caused by Clostridium difficile, meticillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum β-lactamase (ESBL)-producing coliforms [1]. It is already known that these pathogens are associated with antibiotic consumption, with some classes encouraging certain organisms more than others [1], [2], [3]. Intensive use of cephalosporins or quinolones, for example, has been linked with increasing rates of C. difficile, MRSA and/or ESBL-producing coliforms, whilst reduced consumption has facilitated decreased rates of one or more of these pathogens [1], [2], [3], [4], [5]. As a response to high rates of HAIs, it was decided to impose a restrictive antibiotic policy banning the routine use of third-generation cephalosporins, specifically ceftriaxone, and quinolones throughout the hospital. Prospective surveillance programmes were set up to monitor rates of hospital-acquired C. difficile, MRSA and ESBL-producing coliforms. Previous studies have not necessarily monitored the effect of such a policy for a whole hospital, nor have they included surveillance of all three pathogens simultaneously. The aim of stewardship was primarily to reduce the number of C. difficile cases, although it was hoped that the policy would also impact on MRSA and ESBL-producing coliforms. This article describes how prescribing practices were changed and what happened after two key antibiotics were removed from first-line prescribing on a hospital-wide basis.
Section snippets
Antimicrobial policy implementation
Hairmyres Hospital is a 450-bed district general hospital in a rural area just outside Glasgow, UK. The hospital admits adult patients only, specialising in care of the elderly, respiratory, endocrinology and cardiology, with most surgical specialties represented, including orthopaedics, vascular, ear, nose and throat (ENT), and ophthalmology. There is an Accident & Emergency (A&E) department, a high dependency unit and an 8-bed Intensive Care Unit (ICU). Antimicrobial prescribing policies for
Results
Average monthly consumption of ceftriaxone reduced from 46.213 DDDs/1000 pt-bds for January–June 2008 to 2.129 DDDs/1000 pt-bds for June–November 2009 (95% reduction). Over the same periods, ciprofloxacin consumption decreased from 109.804 to 30.205 DDDs/1000 pt-bds (72.5% reduction). The pre-intervention hospital-acquisition MRSA rate during the initial 6 months was 1.187 cases/1000 pt-bds, decreasing to 0.894 cases/1000 pt-bds (25% reduction) for the final 6 months of the study; for C.
Discussion
Introducing and reinforcing a restrictive antimicrobial policy in this hospital had a rapid and profound effect on the rate of hospital-acquired C. difficile. The relationship between consumption of broad-spectrum antibiotics and C. difficile rates has already been established, with the highest risk for C. difficile infection within the first month following antibiotic use [1], [2], [3], [7]. Whilst the most significant association occurred between C. difficile rate and ceftriaxone consumption,
Acknowledgments
Frances Kerr, Catherine Irvine and Margaret Crookston (Pharmacy) helped with antimicrobial consumption data; nurses Christina Coulombe and Lorraine McWilliams helped collect and validate hospital-acquired infection data. The study could not have been performed without support from NHS Lanarkshire Antibiotic & Infection Group and Hairmyres medical staff.
Funding: No funding sources.
Competing interests: Sole conflicts of interest are previous conference support for SJD from Janssen-Cilag, Pfizer
References (20)
- et al.
Modification in prescribing practices for third-generation cephalosporins and ciprofloxacin is associated with a reduction in meticillin-resistant Staphylococcus aureus bacteraemia rate
J Hosp Infect
(2008) - et al.
Spatio-temporal stochastic modelling of Clostridium difficile
J Hosp Infect
(2009) - et al.
Impact of hospital-wide infection rate, invasive procedures use and antimicrobial consumption on bacterial resistance inside an intensive care unit
J Hosp Infect
(2010) - et al.
Comparison of the effect of ciprofloxacin and Tazocin on the incidence of meticillin-resistant Staphylococcus aureus (MRSA) in an intensive care unit
Int J Antimicrob Agents
(2008) - et al.
Rapid acquisition of decreased carbapenem susceptibility in a strain of Klebsiella pneumoniae arising during meropenem therapy
Clin Microbiol Infect
(2012) Antibiotic resistance: understanding how to control it
Int J Antimicrob Agents
(2012)- et al.
Antimicrobial-resistant pathogens in animals and man: prescribing, practices and policies
J Antimicrob Chemother
(2010) - et al.
Antibiotic resistance: synthesis of recommendations by expert policy groups. Alliance for the Prudent Use of Antibiotics
(2001) The problem with cephalosporins
J Antimicrob Chemother
(2001)- et al.
Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years
Infect Control Hosp Epidemiol
(2003)